These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 24532414
1. Effects of L-arginine, mirabegron, and oxybutynin on the primary bladder afferent nerve activities synchronized with reflexic, rhythmic bladder contractions in the rat. Aizawa N, Homma Y, Igawa Y. Neurourol Urodyn; 2015 Apr; 34(4):368-74. PubMed ID: 24532414 [Abstract] [Full Text] [Related]
2. Effects of mirabegron, a novel β3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin. Aizawa N, Homma Y, Igawa Y. Eur Urol; 2012 Dec; 62(6):1165-73. PubMed ID: 22981677 [Abstract] [Full Text] [Related]
3. The role of transient receptor potential ankyrin 1 (TRPA1) channel in activation of single unit mechanosensitive bladder afferent activities in the rat. Minagawa T, Aizawa N, Igawa Y, Wyndaele JJ. Neurourol Urodyn; 2014 Jun; 33(5):544-9. PubMed ID: 23784920 [Abstract] [Full Text] [Related]
4. Inhibitory effects of silodosin on the bladder mechanosensitive afferent activities and their relation with bladder myogenic contractions in male rats with bladder outlet obstruction. Aizawa N, Watanabe D, Fukuhara H, Fujimura T, Kume H, Homma Y, Igawa Y. Neurourol Urodyn; 2018 Aug; 37(6):1897-1903. PubMed ID: 29508437 [Abstract] [Full Text] [Related]
5. Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: new insights into the working mechanism of antimuscarinics. De Laet K, De Wachter S, Wyndaele JJ. Neurourol Urodyn; 2006 Aug; 25(2):156-61. PubMed ID: 16372316 [Abstract] [Full Text] [Related]
6. Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats. Hatanaka T, Ukai M, Watanabe M, Someya A, Ohtake A, Suzuki M, Ueshima K, Sato S, Kaku S. Naunyn Schmiedebergs Arch Pharmacol; 2013 Jan; 386(1):71-8. PubMed ID: 23224420 [Abstract] [Full Text] [Related]
7. Selective inhibitory effect of imidafenacin and 5-hydroxymethyl tolterodine on capsaicin sensitive C fibers of the primary bladder mechanosensitive afferent nerves in the rat. Aizawa N, Ito H, Sugiyama R, Fujimura T, Suzuki M, Fukuhara H, Homma Y, Igawa Y. J Urol; 2015 Apr; 193(4):1423-32. PubMed ID: 25219701 [Abstract] [Full Text] [Related]
8. Combinational effects of muscarinic receptor inhibition and β3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinal cord injury. Wada N, Shimizu T, Takai S, Shimizu N, Tyagi P, Kakizaki H, Yoshimura N. Neurourol Urodyn; 2017 Apr; 36(4):1039-1045. PubMed ID: 27367752 [Abstract] [Full Text] [Related]
9. Inhibitory effects of retigabine, a Kv7 channel activator, on mechanosensitive primary bladder afferent activities and nociceptive behaviors in rats. Aizawa N, Wakamatsu D, Kida J, Otsuki T, Saito Y, Matsuya H, Homma Y, Igawa Y. Neurourol Urodyn; 2017 Feb; 36(2):280-285. PubMed ID: 26536146 [Abstract] [Full Text] [Related]
10. Functional roles of bladder α1-adrenoceptors in the activation of single-unit primary bladder afferent activity in rats. Aizawa N, Sugiyama R, Ichihara K, Fujimura T, Fukuhara H, Homma Y, Igawa Y. BJU Int; 2016 Jun; 117(6):993-1001. PubMed ID: 26332379 [Abstract] [Full Text] [Related]
11. Efficacy of the combination of KPR-5714, a novel transient receptor potential melastatin 8 (TRPM8) antagonist, and β3-adrenoceptor agonist or anticholinergic agent on bladder dysfunction in rats with bladder overactivity. Aizawa N, Fujimori Y, Nakanishi O, Hayashi T, Goi Y, Kobayashi JI, Fujita T. Eur J Pharmacol; 2021 May 15; 899():173995. PubMed ID: 33675781 [Abstract] [Full Text] [Related]
12. Direct influence of systemic desensitization by resiniferatoxin on the activities of Aδ- and C-fibers in the rat primary bladder mechanosensitive afferent nerves. Aizawa N, Fukuhara H, Fujimura T, Homma Y, Igawa Y. Int J Urol; 2016 Nov 15; 23(11):952-956. PubMed ID: 27509829 [Abstract] [Full Text] [Related]
13. Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction. Gillespie JI, Palea S, Guilloteau V, Guerard M, Lluel P, Korstanje C. BJU Int; 2012 Jul 15; 110(2 Pt 2):E132-42. PubMed ID: 22734512 [Abstract] [Full Text] [Related]
15. Protective effect of a β3-adrenoceptor agonist on bladder function in a rat model of chronic bladder ischemia. Sawada N, Nomiya M, Hood B, Koslov D, Zarifpour M, Andersson KE. Eur Urol; 2013 Oct 15; 64(4):664-71. PubMed ID: 23838637 [Abstract] [Full Text] [Related]
16. Effects of TRPV4 cation channel activation on the primary bladder afferent activities of the rat. Aizawa N, Wyndaele JJ, Homma Y, Igawa Y. Neurourol Urodyn; 2012 Jan 15; 31(1):148-55. PubMed ID: 22038643 [Abstract] [Full Text] [Related]
17. Mechanisms of inhibitory action of TRK-130 (Naltalimide), a μ-opioid receptor partial agonist, on the micturition reflex. Fujimura M, Izumimoto N, Kanie S, Kobayashi R, Yoshikawa S, Momen S, Hirakata M, Komagata T, Okanishi S, Iwata M, Hashimoto T, Doi T, Yoshimura N, Kawai K. Int Urol Nephrol; 2017 Apr 15; 49(4):587-595. PubMed ID: 28093646 [Abstract] [Full Text] [Related]
18. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways. Kim Y, Yoshimura N, Masuda H, de Miguel F, Chancellor MB. Urology; 2005 Feb 15; 65(2):238-42. PubMed ID: 15708029 [Abstract] [Full Text] [Related]